Most herbal medicines are orally administered as decoctions. The components of these herbal medicines are therefore inevitably brought into contact with intestinal microflora in the alimentary tract. Most components may be transformed by the intestinal bacteria before absorption from the gastrointestinal tract. Studies on the metabolism of components by human intestinal microflora are of a great importance to an understanding of biological effects.
Acanthopanax species (Araliaceae) have been used in Korea as a tonic and sedative as well as a drug with ginsenglike activities. Four 3,4-seco-lupane type triterpenoids such as chiisanoside, chiisanogenin, 24-hydroxychiisanogenin, 22a-hydroxychiisanogenin have been isolated from the leaves of A. divaricatus var. albeofructus (Araliaceae). 3, 4) Similar constituents have also been isolated from A. senticosus forma inermis. 5) Chiisanogenin has been obtained artificially from chiisanoside by enzymatic hydrolysis with crude hesperidinase. 6) Chiisanoside, the main component of this plant, has been reported to have anti-hepatotoxic activity, antidiabetic activity and effects on mitogen-induced proliferation of lymphocytes, etc. 7, 8) However, no any information about the metabolism of chiisanoside has not been reported yet. The fact that chiisanogenin along with chiisanoside was isolated simultaneously from this plant suggested that this plant might possess an enzyme hydrolyzing the b-D-glucopyranosyl ester bond in the sugar moiety of chiisanoside. Furthermore, if chiisanoside is orally administered to human being, it may not be absorbed intact from the gastrointestinal tract. However, studies on the metabolism of chiisanoside are not complete.
Therefore, to understand the nature of the metabolites of chiisanoside by human intestinal bacteria and how its biological activity changes, we investigated the metabolism of chiisanoside by human intestinal bacteria and its relation to various biological activities.
MATERIALS AND METHODS

Materials
General anaerobic medium (GAM) and glucose blood liver medium (BL) were purchased from Nissui Pharmaceutical Co., Ltd. The other media were purchased from Difco Co. (U.S.A.). Tumor cell lines (P-388, mouse lymphoid neoplasma cell line; L-1210, mouse lymphocytic leukemia cell line; A549, human lung cancer cell line; SNU C4, human colon cancer cell line) were purchased from the Korean Cell Line Bank (Seoul National University, Korea). HP ATCC43504 purchased from ATCC (U.S.A.). Macaccus Rhesus monkey kidney cell (MA-104) was purchased from Korean National Institute of Health, Korea. Wa virus (a wild type of human rotavirus) was kindly donated by Toyama Institute of Health, Japan. Dulbecco's modified eagle's medium (DMEM) and phosphate buffered saline (PBS) were purchased from Sigma Co. (U.S.A.). Antibiotics-antimycotics, trypsin-EDTA (X10) and trypsin (1 : 250) were from Gibco Co. (U.S.A.). Fetal bovine serum (FBS) was from Biofluids Inc. (U.S.A.). Chiisanoside (I) previously isolated from the leaves of A. divaricatus var. albeofructus was used.
3) H ϩ /K ϩ ATPase and b-glucuronidase were partially purified from rat (SD) liver according to the previous method. 9, 10) Instruments Melting points (uncorrected) were determined using an electrothermal digital melting point apparatus. Optical rotations were determined on a JASCO DIP-1000 KUY polarimeter (lϭ0.5). IR spectra were obtained with a Hitachi 270-30 type spectrophotometer. FAB-MS were obtained in a glycerol matrix in the negative ion mode using JEOL JMS-DX300 and JMS-DX303HF instruments. 1 H-NMR spectra were measured in pyridine-d 5 on a JEOL l-400 spectrometer and chemical shifts were relative to TMS. TLC was performed on precoated silica-gel 60F 254 1 mM chiisanoside and 0.5 g fresh human fecal bacteria in a final volume of 10 ml of an anaerobic dilution medium was incubated at 37°C for 15 h. The reaction mixture was extracted three times with 50 ml of ethylacetate. The ethylacetate extract was applied to silica gel column chromatography (1.5ϫ15 cm) with CHCl 3 -MeOH (9 : 1). A main metabolite, II, was crystallized with MeOH and identified to be chiisanogenin by comparison of spectral data with literature. albeofructus Chiisanosidemetabolizing activity was measured as follows. The assay mixture contained 1 mM chiisanoside (or other compounds) and 0.1 g fresh human fecal bacteria (or 0.1 g Bacteroides JY-6, 1 mg of 60% saturated ammonium sulfate fraction of partially purified carboxylesterase from A. divaricatus var. albeofructus) in a final volume of 10 ml of an anaerobic dilution medium. The mixture was incubated at 37°C for 5 h. An aliquot (1 ml) of the reaction mixture was periodically extracted twice with 2 ml of ethylacetate. The ethylacetate fraction was analyzed by TLC. Bacteroides JY-6, which is a main human intestinal bacterium hydrolyzing b-glucosyl carboxylester bond of kalopanasaponin H, was cultured and centrifuged according to our previous method. 11, 12) Carboxylesterase of A. divaricatus var. albeofructus was partially purified as follows. The fresh leaves (50 g) of A. divaricatus var. albeofructus were homogenized in 50 mM phosphate buffer (pH 7.0) and centrifuged. The supernatant was precipitated with 60% saturated ammonium sulfate. The precipitated fraction was dialyzed with 50 mM phosphate buffer and used as a partially purified carboxylesterase.
Thin Layer Chromatography (TLC) TLC for chiisanoside and its metabolite was performed on silica gel plates (Merck, silica gel 60F-254) as follows: developing solvents system, CHCl 3 -MeOH-H 2 O (65 : 35 : 10 v/v/v %); spraying reagent, MeOH-H 2 SO 4 (95 : 5 v/v). The quantities of these compounds were assayed with a TLC scanner (Shimadzu CS-9301PC).
In Vitro Cytotoxicity Assay The in vitro cytotoxicity assay was performed according to the method of Carmichael et al.
13)
Growth Inhibition Assay of HP Growth inhibition assay of HP was performed according to the previous method .14)
Preparation and Assay of HP Urease The preparation of partial purified urease from HP was performed according to our previous method. 14) Urease activity was determined by the indophenol method. 15) Acetohydroxamic acid was used as a positive control.
Assay of b b -Glucuronidase Activity
The enzyme was assayed as follows; Each reaction mixture (2 ml) consisting of 0.8 ml of 2 mM p-nitrophenyl b-D-glucuronide and 0.2 ml of enzyme solution was incubated for 30 min at 37°C and then stopped by addition of 1 ml of 0.5 N NaOH. The stopped reaction mixture was centrifuged at 3000 rpm for 10 min and activity was measured by monitoring the absorbance at 405 nm. 
9)
Culture of Rotavirus and Assay of Inhibitory Activity of Chiisanoside and Chiisagnogenin Culture of rotavirus and the anti-rotaviral activity assay of chiisanoside and chiisanogenin were performed according to our previous methods. 16) 
RESULTS AND DISCUSSION
Metabolism of Chiisanoside by Human Intestinal Bacteria
To investigate the metabolite of chiisanoside by human intestinal bacteria, chiisanoside was anaerobically incubated for 15 h with a bacterial mixture from human feces. The metabolite was extracted with ethylacetate, separated by silica gel column chromatography, and analyzed by TLC, 13 1 H-and 13 C-NMR spectra of II showed that triterpenoid skeleton of chiisanoside was intact but two glucosyl and one rhamnosyl moieties were missing. By these results, II was identified to be chiisanogenin, which was previously isolated from the leaves of A. divaricatus var. albeofructus. 3) To evaluate biotransformation of chiisanoside and its derivatives in the intestine of humans and A. divaricatus var. albeofructus, the compound was incubated with human intestinal bacteria or the protein fraction of the leaves of A. divaricatus var. albeofructus and their transforming activities were measured (Fig. 1) . Compound II was a major metabolite 1 h after incubation with the protein fraction of the leaves of A. divaricatus var. albeofructus as well as human intestinal microflora. Both metabolic systems directly transformed chiisanoside to II. Therefore, we suggest that chiisanoside can be easily transformed to its aglycone, chiisanogenin, in the intestine by human intestinal bacteria. However, the protein fraction (carboxylesterase) of A. divaricatus var. albeofructus potently catalyzed converstion of chiisanoside to its aglycone compared to intestinal bacteria. We also measured the metabolic activity of chiisanoside, acantrifoside A, acankoreoside A and acankoreoside D by intestinal bacteria or carboxylesterase. These compounds were also potently transformed to their aglycones. Among them, the metabolism of both acantrifoside A and acankoreside D was the most potent with both enzymes. In addition, we could isolate chiisanogenin with chiisanoside as a main component from the leaves of A. divaricatus var. albeofructus. These results may be because the leaves of A. divaricatus var. albeofructus produce a potent carboxylesterase. Therefore, we suggest that the carboxylesterase of the leaves of A. divaricatus var. albeofructus may be the enzyme related to the defense system because chiisanogenin is more bioactive than chiisanoside.
Biological Activity of Chiisanoside and Chiisanogenin To understand the metabolism of chiisanoside by human intestinal bacteria and how its biological activity changes, we determined the inhibitory activity of chiisanoside and its metabolite, chiisanogenin, on b-glucuronidase, H (Tables  2, 3 ). Chiisanoside and chiisanogenin weakly inhibited bglucuronidase. These results suggest that these compounds may play important roles in prevenion of liver damage, because b-glucuronidase is related to liver toxification. 17) Chiisanoside inhibited rotavirus infection, but chiisanogenin did not. Rotavirus has been recognized as a major cause of diarrhea, primarily in the neonatal period. Therefore, chiisanoside is believed to contribute to the prevention of rotaviral illness to some degree.
ϩ into the stomach. Therefore, chiisanogenin may protect from ulcer of stomach. However, both chiisanoside and chiisanogenin did not inhibit HP urease and HP growth. Therefore, these compounds should not eradicate gastritis caused by HP.
The in vitro cytotoxicity of chiisanoside and chiisanogenin against tumor cell lines was assayed (Table 4) . Chiisanogenin showed more potent cytotoxicity against tumor cell lines than that of chiisanoside. Its ED 50 value was 0.5 mg/ml. We found that the cytotoxicity was increased when the glycoside of chiisanoside were metabolized to its aglycone by human intestinal microflora. These results suggested that most natural glycosides are prodrugs which can be transformed to active compounds by intestinal microflora, even if some of the biological activity of these glycosides, such as inhibition of rotavirus infection, disappears. 
